NEA Management Company, LLC Q3 2021 Filing
Filed November 12, 2021
Portfolio Value
$8.4T
Holdings
63
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (63 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HOODROBINHOOD MKTS INC | 74,818,398 | $3.1T | 37.40% | |
| 2 | —BRIGHT HEALTH GROUP INC | 218,212,128 | $1.8T | 21.15% | |
| 3 | COURCOURSERA INC | 15,867,769 | $502.2B | 5.97% | |
| 4 | CVRXCVRX INC | 2,370,858 | $392.1B | 4.66% | |
| 5 | —BERKSHIRE GREY INC | 38,226,621 | $268.7B | 3.19% | |
| 6 | ALLKGUSDALLAKOS INC | 2,164,704 | $229.2B | 2.72% | |
| 7 | CRSPCRISPR THERAPEUTICS AG | 1,590,002 | $178.0B | 2.11% | |
| 8 | GLUEMONTE ROSA THERAPEUTICS INC | 7,703,205 | $171.6B | 2.04% | |
| 9 | BILLBILL COM HLDGS INC | 560,774 | $149.7B | 1.78% | |
| 10 | AUPHAURINIA PHARMACEUTICALS INC | 5,172,683 | $114.5B | 1.36% | |
| 11 | TREURTRILLIUM THERAPEUTICS INC | 5,736,363 | $100.7B | 1.20% | |
| 12 | NETCLOUDFLARE INC | 889,759 | $100.2B | 1.19% | |
| 13 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 17,082,611 | $88.3B | 1.05% | |
| 14 | MIRMMIRUM PHARMACEUTICALS INC | 4,187,801 | $83.4B | 0.99% | |
| 15 | NKTXNKARTA INC | 2,904,974 | $80.8B | 0.96% | |
| 16 | OYSTOYSTER PT PHARMA INC | 5,925,287 | $70.2B | 0.83% | |
| 17 | RYTMRHYTHM PHARMACEUTICALS INC | 4,912,306 | $64.2B | 0.76% | |
| 18 | —VECTIVBIO HLDG AG | 67,069 | $51.8B | 0.62% | |
| 19 | —AKOUOS INC | 4,298,488 | $49.9B | 0.59% | |
| 20 | VTGNUSDVISTAGEN THERAPEUTICS INC | 16,302,596 | $44.7B | 0.53% | |
| 21 | ANNXANNEXON INC | 2,358,606 | $43.9B | 0.52% | |
| 22 | OKURRENEO PHARMACEUTICALS INC | 4,786,921 | $35.7B | 0.42% | |
| 23 | GRTXGALERA THERAPEUTICS INC | 4,362,986 | $35.3B | 0.42% | |
| 24 | —METROMILE INC | 9,384,285 | $33.3B | 0.40% | |
| 25 | YB4PSAVARA INC | 24,137,931 | $33.3B | 0.40% | |
| 26 | —EARGO INC | 4,520,670 | $30.4B | 0.36% | |
| 27 | BDTXBLACK DIAMOND THERAPEUTICS INC | 3,449,845 | $29.2B | 0.35% | |
| 28 | INZYINOZYME PHARMA INC | 2,444,379 | $28.3B | 0.34% | |
| 29 | VRNAVERONA PHARMA PLC | 5,108,563 | $27.9B | 0.33% | |
| 30 | —AFFIMED NV | 4,426,488 | $27.4B | 0.32% | |
| 31 | —CASPER SLEEP INC | 6,226,130 | $26.6B | 0.32% | |
| 32 | BEBLOOM ENERGY CORP | 1,333,333 | $25.0B | 0.30% | |
| 33 | 0HJQAVEO PHARMACEUTICALS INC | 3,952,958 | $24.4B | 0.29% | |
| 34 | MEIPUSDMEI PHARMA INC | 8,533,072 | $23.6B | 0.28% | |
| 35 | CTIC1USDCTI BIOPHARMA CORP | 7,140,450 | $21.1B | 0.25% | |
| 36 | —PHASEBIO PHARMACEUTICALS INC | 6,643,704 | $20.7B | 0.25% | |
| 37 | GNCAQGENOCEA BIOSCIENCES INC | 10,376,936 | $19.9B | 0.24% | |
| 38 | GLYCEURGLYCOMIMETICS INC | 9,089,041 | $19.9B | 0.24% | |
| 39 | GONGERON CORP | 13,461,538 | $18.4B | 0.22% | |
| 40 | IVAINVENTIVA SA | 1,298,700 | $18.4B | 0.22% | |
| 41 | TPIVDEURMARKER THERAPEUTICS INC | 10,714,285 | $18.1B | 0.22% | |
| 42 | ARDXARDELYX INC | 13,633,582 | $18.0B | 0.21% | |
| 43 | CSBRCHAMPIONS ONCOLOGY INC | 1,713,720 | $17.5B | 0.21% | |
| 44 | —IMARA INC | 4,017,170 | $16.4B | 0.19% | |
| 45 | XENEXENON PHARMACEUTICALS INC | 992,107 | $15.2B | 0.18% | |
| 46 | —SATSUMA PHARMACEUTICALS INC | 3,142,958 | $14.6B | 0.17% | |
| 47 | —OBSEVA SA | 4,586,563 | $14.3B | 0.17% | |
| 48 | —SYNLOGIC INC | 4,229,410 | $12.9B | 0.15% | |
| 49 | LXRXLEXICON PHARMACEUTICALS INC | 2,382,286 | $11.5B | 0.14% | |
| 50 | —METACRINE INC | 3,062,977 | $10.5B | 0.12% | |
| 51 | —DESKTOP METAL INC | 14,407,594 | $10.3B | 0.12% | |
| 52 | —STRONGBRIDGE BIOPHARMA PLC | 4,141,308 | $8.4B | 0.10% | |
| 53 | TRVITREVI THERAPEUTICS INC | 5,940,796 | $8.3B | 0.10% | |
| 54 | LQDALIQUIDIA TECHNOLOGIES INC | 2,486,062 | $6.9B | 0.08% | |
| 55 | 4NX1LUMOS PHARMA INC | 526,663 | $5.0B | 0.06% | |
| 56 | —TREVENA INC | 3,811,691 | $4.7B | 0.06% | |
| 57 | —REGULUS THERAPEUTICS INC | 6,451,056 | $4.5B | 0.05% | |
| 58 | ERYP1EURERYTECH PHARMA SA | 625,000 | $3.6B | 0.04% | |
| 59 | OVASUSDTEMPEST THERAPEUTICS INC | 117,785 | $1.7B | 0.02% | |
| 60 | ADXNUSDADDEX THERAPEUTICS LTD | 180,000 | $1.6B | 0.02% | |
| 61 | TCONTRACON PHARMACEUTICALS INC | 346,718 | $1.3B | 0.02% | |
| 62 | —AKARI THERAPEUTICS PLC | 452,167 | $737.0M | 0.01% | |
| 63 | RYIVIRACTA THERAPEUTICS INC | 37,093 | $297.0M | 0.00% |